Minireviews
Copyright ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Urol. Mar 24, 2017; 6(1): 10-17
Published online Mar 24, 2017. doi: 10.5410/wjcu.v6.i1.10
Chronic kidney disease after radical nephrectomy for suspected renal cancers
Tuck Y Yong, Kareeann S F Khow
Tuck Y Yong, Internal Medicine, Flinders Private Hospital, Bedford Park, South Australia 5042, Australia
Kareeann S F Khow, Adelaide Geriatrics Teaching and Research with Aged Care, the University of Adelaide, Paradise, South Australia 5075, Australia
Author contributions: Yong TY and Khow KSF designed, performed the research and wrote the paper.
Conflict-of-interest statement: The authors have no financial relationships to disclose.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Tuck Y Yong, FRACP, Internal Medicine, Flinders Private Hospital, Flinders Drive, Bedford Park, South Australia 5042, Australia. tyyong@hotmail.com
Telephone: +61-8-82412121 Fax: +61-8-82400879
Received: August 28, 2016
Peer-review started: September 1, 2016
First decision: November 30, 2016
Revised: December 29, 2016
Accepted: January 11, 2017
Article in press: January 13, 2017
Published online: March 24, 2017
Processing time: 185 Days and 16.3 Hours
Core Tip

Core tip: Chronic kidney disease (CKD) is an important complication associated with radical nephrectomy. CKD post-nephrectomy is associated with increased risk of cardiovascular diseases. Risk factors for CKD should be assessed thoroughly before radical nephrectomy. Where possible, nephron-sparing treatment should be used to mitigate the onset of CKD after tumour resection.